Inspire Medical Systems Shares Dip 1.4% After FDA Approves Eli Lilly's Zepbound
Inspire Medical Systems stock drops 1.4% as Eli Lilly's Zepbound gains FDA approval, impacting the sleep apnea market.
Topic
INSP
A collection of 1 issue